3,331
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection

, , , , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ORCID Icon & show all
Pages 1329-1337 | Received 10 Jun 2021, Accepted 02 Sep 2021, Published online: 19 Sep 2021

References

  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
  • Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020;31(6):1157–1165.
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
  • Ng JJ, Luo Y, Phua K, et al. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): a meta-analysis. J Infect. 2020;81(4):647–679.
  • Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32(1):151–160.
  • Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
  • Gross O, Moerer O, Weber M, et al. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020;395(10236):e87–e88.
  • Puelles VG, Lutgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590–592.
  • Qi F, Qian S, Zhang S, et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526(1):135–140.
  • Wu C, Ye D, Mullick AE, et al. Effects of renin-angiotensin inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) expression: insights into COVID-19. Hypertension. 2020;76(4):e29–e30.
  • Naicker S, Yang CW, Hwang SJ, et al. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97(5):824–828.
  • Golmai P, Larsen CP, DeVita MV, et al. Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19. J Am Soc Nephrol. 2020;31(9):1944–1947.
  • Sharma P, Uppal NN, Wanchoo R, et al. COVID-19-Associated kidney injury: a case series of kidney biopsy findings. J Am Soc Nephrol. 2020;31(9):1948–1958.
  • Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
  • Kenny AP, Glen AC. Tests of phosphate reabsorption. Lancet. 1973;2(7821):158.
  • Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet. 1975;2(7929):309–310.
  • Yang X, Jin Y, Li R, et al. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and Meta-analysis. Crit Care. 2020;24(1):356.
  • Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets. 2020;31(5):674–679.
  • Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with covid-19. J Thromb Haemost. 2020;18(6):1324–1329.
  • Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. BMJ. 2020;369:m1966.
  • Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472.
  • Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.
  • Wang L, Xiao C, Chen L, et al. Impact of hypophosphatemia on outcome of patients in intensive care unit: a retrospective cohort study. BMC Anesthesiol. 2019;19(1):86.
  • Aubier M, Murciano D, Lecocguic Y, et al. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med. 1985;313(7):420–424.
  • Broman M, Wilsson AMJ, Hansson F, et al. Analysis of hypo- and hyperphosphatemia in an intensive care unit cohort. Anesth Analg. 2017;124(6):1897–1905.
  • Kilic O, Demirkol D, Ucsel R, et al. Hypophosphatemia and its clinical implications in critically ill children: a retrospective study. J Crit Care. 2012;27(5):474–479.
  • Geerse DA, Bindels AJ, Kuiper MA, et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010;14(4):R147.
  • Thongprayoon C, Cheungpasitporn W, Mao MA, et al. Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients. J Nephrol. 2018;31(2):241–247.
  • Cheungpasitporn W, Thongprayoon C, Mao MA, et al. Admission serum phosphate levels predict hospital mortality. Hosp Pract. 2018;46(3):121–127.
  • Boot R, Koekkoek K, van Zanten ARH. Refeeding syndrome: relevance for the critically ill patient. Curr Opin Crit Care. 2018;24(4):235–240.
  • Bech A, Blans M, Telting D, et al. Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit. Intensive Care Med. 2013;39(10):1785–1791.
  • Akilesh S, Nast CC, Yamashita M, et al. Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria. Am J Kidney Dis. 2021;77(1):82–93.e81.
  • Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185–192.
  • Perico L, Benigni A, Casiraghi F, et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17(1):46–64.
  • Yu F, Yan L, Wang N, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020;71(15):793–798.
  • Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol. 2020;31(8):1683–1687.
  • Miller SE, Goldsmith CS. Caution in identifying coronaviruses by electron microscopy. J Am Soc Nephrol. 2020;31(9):2223–2224.
  • Shetty AA, Tawhari I, Safar-Boueri L, et al. COVID-19-Associated glomerular disease. J Am Soc Nephrol. 2021;32(1):33–40.
  • Werion AB, Perrot M, Schmit G, et al. On behalf of the CUSL COVID-19 research group, SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int. 2020;98(5):1296–1307.
  • Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118(10):1094–1101.